Back to 
Citadel Advisors LLC
Citadel Advisors LLC
PASG
3 quarters
Position history for Citadel Advisors LLC's holdings in Passage Bio, Inc.
No. Citadel Advisors exited its PASG (Passage Bio) position in Q1 2026. Its Q4 2025 13F listed 17,660 shares worth $208,388. Citadel Advisors first reported PASG in Q3 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$152,919
Total Shares Change
-19,091
Quarter-by-Quarter History
Other major holders of PASG: Vanguard Group Inc., Renaissance Technologies LLC, Erste Asset Management GmbH